Gefitinib.

The article describes two cases of superficial dermatophytosis-like reaction in two women following treatment with oral gefitinib 250 milligram/day for stage IV non-small cell lung cancer. It references a study by S.-S. Lin et al, published in the June 2009 issue of the journal "Clinical and Experimental Dermatology." The medical history of each patient is presented. Manifestations of the reaction include painful erythematous swellings on the patient's fingers and toes and hair loss. Treatment with a tar-based shampoo is cited.